We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Researchers Culture Novel Three-Dimensional Artificial Tumors

By LabMedica International staff writers
Posted on 07 Dec 2015
A team of Canadian cancer researchers has developed a novel method for growing three-dimensional cultures of cancer cells that behave as artificial tumors and which can be readily resolved to evaluate the response of individual cells to different levels of oxygen and nutrients.

The cells growing in the center of a tumor have reduced access to oxygen and nutrients as compared to those growing near the surface, nearer to blood vessels. More...
These subtle, location-dependent environment differences influence cell behavior, but their effect has proven difficult to replicate in laboratory culture.

Investigators at the University of Toronto (ON, Canada) have reported the development of a novel culture system in the form of a rolled-up sheet that mimics the three-dimensional environment of a tumor, yet can also be taken apart in seconds.

The investigators impregnated a short strip of a porous, paper-like support material with collagen and cancer cells. The strip was then incubated for 24 hours in a nutrient-rich culture solution, which allowed the cells to adjust to their new environment. The strip was then rolled around a metal core, forming an artificial tumor, which was then cultured for several more days before performing analysis of tumor cell behavior. By unrolling the strip, the model could be rapidly disassembled for snapshot analysis, allowing spatial mapping of cell metabolism in concert with cell phenotype.

Results published in the November 23, 2015, online edition of the journal Nature Materials revealed that as the oxygen level decreased in internal areas of the tumor roll, the number of dead cells increased, which indicated that the cells had responded to the oxygen gradient.

Cells able to live under hypoxic conditions were found to behave differently than the surface cells: for example, they more strongly expressed genes associated with low oxygen conditions. Changes in gene expression, as determined by liquid chromatography tandem mass spectrometry metabolic signature analysis, were gradual and continuous along the length of the strip.

Senior author Dr. Alison McGuigan, professor of chemical engineering at the University of Toronto, said, "The technology holds great promise for the field of personalized medicine. The idea would be to take a patient's own cells and create copies of their tumor. These copies could then be subjected to various treatments and analyzed by the simple unrolling process, providing information about what is likely to work best for that specific patient. It is very translatable and transferable to other labs. We definitely want others to use it, because the larger the community, the more applications we will discover."

Related Links:
University of Toronto



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
All-in-One Molecular System
AIO M160
New
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.